Recombinant GPI-anchored TIMP-1 stimulates growth and migration of peritoneal mesothelial cells

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Djafarzadeh, Roghieh ^a   Sauter, Matthias ^a   Notohamiprodjo, Susan ^a   Noessner, Elfriede ^b   Goyal, Pankaj ^c   Siess, Wolfgang ^c   Wörnle, Markus ^a   Ribeiro, Andrea ^a   Himmelein, Susanne ^a   Sitter, Thomas ^a   Nelson, Peter J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1 GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN FUSION PROTEIN; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UROKINASE; WOUND HEALING PROMOTING AGENT; GLYCOSYLPHOSPHATIDYLINOSITOL; RECOMBINANT PROTEIN;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; MESOTHELIUM CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; WOUND HEALING; CELL CULTURE; CELL MOTION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PERITONEUM;

CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROSCOPY, FLUORESCENCE; PERITONEUM; RECOMBINANT PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; WOUND HEALING;

EID: 84860441448     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033963     Document Type: Article

References (49)

1. Visse R, Nagase H, (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839.
2. Nagase H, Brew K, (2003) Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors. Biochem Soc Symp pp. 201-212.
3. Edwards JG, McLaren J, Jones JL, Waller DA, O'Byrne KJ, (2003) Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura. Br J Cancer 88: 1553-1559.
4. Marshall BC, Santana A, Xu QP, Petersen MJ, Campbell EJ, et al. (1993) Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. J Clin Invest 91: 1792-1799.
5. Raggi MC, Djafarzadeh R, Muenchmeier N, Hofstetter M, Jahn B, et al. (2009) Peritumoral administration of GPI-anchored TIMP-1 inhibits colon carcinoma growth in Rag-2 gamma chain-deficient mice. Biol Chem 390: 893-897.
6. Djafarzadeh R, Mojaat A, Vicente AB, von Luttichau I, Nelson PJ, (2004) Exogenously added GPI-anchored tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) displays enhanced and novel biological activities. Biol Chem 385: 655-663.
7. Djafarzadeh R, Noessner E, Engelmann H, Schendel DJ, Notohamiprodjo M, et al. (2006) GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing. Oncogene 25: 1496-1508.
8. Djafarzadeh R, Milani V, Rieth N, von Luettichau I, Skrablin PS, et al. (2009) TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis. Cancer Immunol Immunother 58: 361-371.
9. Wornle M, Sauter M, Kastenmuller K, Ribeiro A, Mussack T, et al. (2009) Role of viral receptors TLR3, RIG-I and MDA5 in mesothelial tissue-type plasminogen activator and plasminogen activator inhibitor-1 synthesis. Thromb Haemost 101: 1128-1137.
10. Haslinger B, Mandl-Weber S, Sellmayer A, Lederer SR, Sitter T, (2001) Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: involvement of protein kinase C. Nephron 87: 346-351.
11. Kirby AC, Hill V, Olsen I, Porter SR, (1995) LFA-3 delta D2: a novel in vivo isoform of lymphocyte function-associated antigen 3. Biochem Biophys Res Commun 214: 200-205.
12. Medof ME, Nagarajan S, Tykocinski ML, (1996) Cell-surface engineering with GPI-anchored proteins. FASEB J 10: 574-586.
13. Kim JJ, Li JJ, Kim KS, Kwak SJ, Jung DS, et al. (2008) High glucose decreases collagenase expression and increases TIMP expression in cultured human peritoneal mesothelial cells. Nephrol Dial Transplant 23: 534-541.
14. Mack M, Riethmuller G, Kufer P, (1995) A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity. Proc Natl Acad Sci U S A 92: 7021-7025.
15. Fukudome K, Fujimoto S, Sato Y, Hisanaga S, Eto T, (2001) Peritonitis increases MMP-9 activity in peritoneal effluent from CAPD patients. Nephron 87: 35-41.
16. Klier CM, Nelson EL, Cohen CD, Horuk R, Schlondorff D, et al. (2001) Chemokine-Induced secretion of gelatinase B in primary human monocytes. Biol Chem 382: 1405-1410.
17. Whitaker D, Papadimitriou JM, Walters M, (1982) The mesothelium: its fibrinolytic properties. J Pathol 136: 291-299.
18. Iakhiaev AV, Nalian A, Koenig K, Idell S, (2007) Thrombin-thrombomodulin inhibits prourokinase-mediated pleural mesothelial cell-dependent fibrinolysis. Thromb Res 120: 715-725.
19. Sitter T, Spannagl M, Schiffl H, Held E, van Hinsbergh VW, et al. (1995) Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells. Nephrol Dial Transplant 10: 677-683.
20. Sitter T, Toet K, Fricke H, Schiffl H, Held E, et al. (1996) Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators. Am J Physiol 271: R1256-1263.
21. Brauner A, Hylander B, Wretlind B, (1996) Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 27: 402-408.
22. Chen JY, Chi CW, Chen HL, Wan CP, Yang WC, et al. (2003) TNF-alpha renders human peritoneal mesothelial cells sensitive to anti-Fas antibody-induced apoptosis. Nephrol Dial Transplant 18: 1741-1747.
23. Roberts AB, (1998) Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24: 111-119.
24. Loureiro J, Aguilera A, Selgas R, Sandoval P, Albar-Vizcaino P, et al. (2011) Blocking TGF-beta1 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol 22: 1682-1695.
25. Lv ZD, Na D, Ma XY, Zhao C, Zhao WJ, et al. (2011) Human peritoneal mesothelial cell transformation into myofibroblasts in response to TGF-ss1 in vitro. Int J Mol Med 27: 187-193.
26. Eming SA, Brachvogel B, Odorisio T, Koch M, (2007) Regulation of angiogenesis: wound healing as a model. Prog Histochem Cytochem 42: 115-170.
27. Hardman MJ, Waite A, Zeef L, Burow M, Nakayama T, et al. (2005) Macrophage migration inhibitory factor: a central regulator of wound healing. Am J Pathol 167: 1561-1574.
28. Werner S, Krieg T, Smola H, (2007) Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol 127: 998-1008.
29. Yung S, Chan TM, (2009) Intrinsic cells: mesothelial cells - central players in regulating inflammation and resolution. Perit Dial Int 29 (Suppl 2): S21-27.
30. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, et al. (2002) Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13: 470-479.
31. Williams JD, Craig KJ, Topley N, Williams GT, (2003) Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Supplpp. S158-161.
32. Gotloib L, (2009) The mesothelium under the siege of dialysis solutions: old glucose, new glucose, and glucose-free osmotic agents. Adv Perit Dial 25: 6-10.
33. Nagase H, (1998) Cell surface activation of progelatinase A (proMMP-2) and cell migration. Cell Res 8: 179-186.
34. Wojtowicz-Praga SM, Dickson RB, Hawkins MJ, (1997) Matrix metalloproteinase inhibitors. Invest New Drugs 15: 61-75.
35. Yu AE, Hewitt RE, Connor EW, Stetler-Stevenson WG, (1997) Matrix metalloproteinases. Novel targets for directed cancer therapy. Drugs Aging 11: 229-244.
36. Singer CF, Marbaix E, Lemoine P, Courtoy PJ, Eeckhout Y, (1999) Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. Eur J Biochem 259: 40-45.
37. Jonjic N, Peri G, Bernasconi S, Sciacca FL, Colotta F, et al. (1992) Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 176: 1165-1174.
38. Li FK, Davenport A, Robson RL, Loetscher P, Rothlein R, et al. (1998) Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression. Kidney Int 54: 2170-2183.
39. Dobbie JW, (1997) Advanced glycosylation end products in peritoneal tissue with different solutions. Perit Dial Int 17 (Suppl 2): S27-30.
40. diZerega GS, Campeau JD, (2001) Peritoneal repair and post-surgical adhesion formation. Hum Reprod Update 7: 547-555.
41. van der Wal JB, Jeekel J, (2007) Biology of the peritoneum in normal homeostasis and after surgical trauma. Colorectal Dis 9 (Suppl 2): 9-13.
42. Scott-Coombes DM, Whawell SA, Thompson JN, (1995) The operative peritoneal fibrinolytic response to abdominal operation. Eur J Surg 161: 395-399.
43. Baricos WH, Cortez SL, el-Dahr SS, Schnaper HW, (1995) ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 47: 1039-1047.
44. Haslinger-Loffler B, Bruck M, Grundmeier M, Peters G, Sinha B, (2007) Staphylococcal infections impair the mesothelial fibrinolytic system: the role of cell death and cytokine release. Thromb Haemost 98: 813-822.
45. Cohen CD, Kretzler M, (2003) Gene-expression analysis of microdissected renal biopsies. Methods Mol Med 86: 285-293.
46. Yao V, Platell C, Hall JC, (2004) Peritoneal mesothelial cells produce inflammatory related cytokines. ANZ J Surg 74: 997-1002.
47. Yu Q, Stamenkovic I, (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14: 163-176.
48. Morrison CJ, Butler GS, Rodriguez D, Overall CM, (2009) Matrix metalloproteinase proteomics: substrates, targets, and therapy. Curr Opin Cell Biol 21: 645-653.
49. Banas B, Wornle M, Berger T, Nelson PJ, Cohen CD, et al. (2002) Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis. J Immunol 168: 4301-4307.